Idarucizumab (Praxbind) for Reversal of Pradaxa Prior to Emergent Repair of Contained Ruptured Transverse Arch Aneurysm

Idarucizumab before cardiopulmonary bypass was used for the reversal of dabigatran during an emergent frozen elephant trunk repair of a transverse arch aneurysm. Reversal was successful and minimal not massive transfusion was required with no abnormal sequelae seen with use before cardiopulmonary by...

Descripción completa

Detalles Bibliográficos
Autores principales: Belli, Erol Vahit, Lee, Teng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5535586/
https://www.ncbi.nlm.nih.gov/pubmed/28701610
http://dx.doi.org/10.4103/0971-9784.210426
_version_ 1783253865607462912
author Belli, Erol Vahit
Lee, Teng
author_facet Belli, Erol Vahit
Lee, Teng
author_sort Belli, Erol Vahit
collection PubMed
description Idarucizumab before cardiopulmonary bypass was used for the reversal of dabigatran during an emergent frozen elephant trunk repair of a transverse arch aneurysm. Reversal was successful and minimal not massive transfusion was required with no abnormal sequelae seen with use before cardiopulmonary bypass.
format Online
Article
Text
id pubmed-5535586
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-55355862017-08-14 Idarucizumab (Praxbind) for Reversal of Pradaxa Prior to Emergent Repair of Contained Ruptured Transverse Arch Aneurysm Belli, Erol Vahit Lee, Teng Ann Card Anaesth Case Report Idarucizumab before cardiopulmonary bypass was used for the reversal of dabigatran during an emergent frozen elephant trunk repair of a transverse arch aneurysm. Reversal was successful and minimal not massive transfusion was required with no abnormal sequelae seen with use before cardiopulmonary bypass. Medknow Publications & Media Pvt Ltd 2017 /pmc/articles/PMC5535586/ /pubmed/28701610 http://dx.doi.org/10.4103/0971-9784.210426 Text en Copyright: © 2017 Annals of Cardiac Anaesthesia http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Case Report
Belli, Erol Vahit
Lee, Teng
Idarucizumab (Praxbind) for Reversal of Pradaxa Prior to Emergent Repair of Contained Ruptured Transverse Arch Aneurysm
title Idarucizumab (Praxbind) for Reversal of Pradaxa Prior to Emergent Repair of Contained Ruptured Transverse Arch Aneurysm
title_full Idarucizumab (Praxbind) for Reversal of Pradaxa Prior to Emergent Repair of Contained Ruptured Transverse Arch Aneurysm
title_fullStr Idarucizumab (Praxbind) for Reversal of Pradaxa Prior to Emergent Repair of Contained Ruptured Transverse Arch Aneurysm
title_full_unstemmed Idarucizumab (Praxbind) for Reversal of Pradaxa Prior to Emergent Repair of Contained Ruptured Transverse Arch Aneurysm
title_short Idarucizumab (Praxbind) for Reversal of Pradaxa Prior to Emergent Repair of Contained Ruptured Transverse Arch Aneurysm
title_sort idarucizumab (praxbind) for reversal of pradaxa prior to emergent repair of contained ruptured transverse arch aneurysm
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5535586/
https://www.ncbi.nlm.nih.gov/pubmed/28701610
http://dx.doi.org/10.4103/0971-9784.210426
work_keys_str_mv AT bellierolvahit idarucizumabpraxbindforreversalofpradaxapriortoemergentrepairofcontainedrupturedtransversearchaneurysm
AT leeteng idarucizumabpraxbindforreversalofpradaxapriortoemergentrepairofcontainedrupturedtransversearchaneurysm

Ejemplares similares